What does NOORD LIMBURGSE DIENST UROLOGIE do?

NOORD LIMBURGSE DIENST UROLOGIE is a specialist medical practice in Pelt. Private Limited, started on 27 November 2018, 1 establishment.

What is the address of NOORD LIMBURGSE DIENST UROLOGIE?

The registered office of NOORD LIMBURGSE DIENST UROLOGIE is located at Wildlaan 41, 3910 Pelt.

Is NOORD LIMBURGSE DIENST UROLOGIE still active?

Yes. According to the CBE (19 September 2026) NOORD LIMBURGSE DIENST UROLOGIE is active, legal situation “Normale toestand”, started on 27 November 2018.

Is NOORD LIMBURGSE DIENST UROLOGIE registered on Peppol?

Yes, NOORD LIMBURGSE DIENST UROLOGIE is registered on the Peppol network with ID 0208:0713955929.

What is the enterprise number of NOORD LIMBURGSE DIENST UROLOGIE?

The enterprise number of NOORD LIMBURGSE DIENST UROLOGIE is BE0713955929.

When was NOORD LIMBURGSE DIENST UROLOGIE founded?

NOORD LIMBURGSE DIENST UROLOGIE was founded on 27 November 2018.

Is NOORD LIMBURGSE DIENST UROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 November 2018; 5 annual accounts filed, latest fiscal year 2025; 5 directors known from the annual account.

How much profit did NOORD LIMBURGSE DIENST UROLOGIE make in 2025?

NOORD LIMBURGSE DIENST UROLOGIE posted a profit after taxes of € 0 in financial year 2025.

What is the revenue of NOORD LIMBURGSE DIENST UROLOGIE?

As a small company, NOORD LIMBURGSE DIENST UROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 486,386.

How much does an employee at NOORD LIMBURGSE DIENST UROLOGIE earn?

The average wage cost per full-time employee at NOORD LIMBURGSE DIENST UROLOGIE was € 99,900 in 2025: staff costs of € 459,367 for 4.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does NOORD LIMBURGSE DIENST UROLOGIE have?

According to the 2025 annual accounts, NOORD LIMBURGSE DIENST UROLOGIE has 4.6 full-time equivalents (FTE).

NOORD LIMBURGSE DIENST UROLOGIE (Private Limited) - Pelt

Q: Who are the directors of NOORD LIMBURGSE DIENST UROLOGIE?

According to the 2025 annual accounts, the directors of NOORD LIMBURGSE DIENST UROLOGIE are: Dr. K. De Coster BV, Naturo BV, Dr. Van Dyck Johan BV, Dr. Stijn Schapmans BV, Dokter Tom Vandewalle BV.

Dossier NOORD LIMBURGSE DIENST UROLOGIE, printed on 19 September 2026 from databakkes.be/en/0713955929/noord-limburgse-dienst-urologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

NOORD LIMBURGSE DIENST UROLOGIE from Pelt, company number BE0713955929, closed financial year 2025 with a result of € 0 after tax. For that financial year NOORD LIMBURGSE DIENST UROLOGIE recorded a gross margin of € 486,386 and equity of € 70,067. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Healthy

€ 70,067

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit

€ 0

Profit after tax over the fiscal year.

Cash in the bank

€ 232,811

▲ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 63,867.

People and assets in 2025

Full-time equivalents

4.6

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 459,367

▲ 8% vs 2024

€ 99,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 40,256

▼ 49% vs 2024

€ 14,179 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 320,054

▲ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 43,762

▼ 41% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 410,057 Gross margin 2022: € 410,057 First fiscal year in the series	€ 470,330 Gross margin 2023: € 470,330 ▲ 15% vs 2022 (€ 410,057) Favourable step	€ 457,258 Gross margin 2024: € 457,258 ▼ 3% vs 2023 (€ 470,330) Unfavourable step	€ 486,386 Gross margin 2025: € 486,386 ▲ 6% vs 2024 (€ 457,258) Favourable step	▲ 6%
Profit after taxes	€ 12,690 Profit after taxes 2022: € 12,690 First fiscal year in the series	€ 0 Profit after taxes 2023: € 0 ▼ 100% vs 2022 (€ 12,690) Unfavourable step	€ 0 Profit after taxes 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Profit after taxes 2025: € 0 Unchanged (€ 0) Unchanged
Equity	€ 70,067 Equity 2022: € 70,067 First fiscal year in the series	€ 70,067 Equity 2023: € 70,067 Unchanged (€ 70,067) Unchanged	€ 70,067 Equity 2024: € 70,067 Unchanged (€ 70,067) Unchanged	€ 70,067 Equity 2025: € 70,067 Unchanged (€ 70,067) Unchanged
Total debts	€ 685,670 Total debts 2022: € 685,670 First fiscal year in the series	€ 934,472 Total debts 2023: € 934,472 ▲ 36% vs 2022 (€ 685,670) Unfavourable step	€ 1,126,523 Total debts 2024: € 1,126,523 ▲ 21% vs 2023 (€ 934,472) Unfavourable step	€ 1,036,962 Total debts 2025: € 1,036,962 ▼ 8% vs 2024 (€ 1,126,523) Favourable step	▼ 8%
Cash	€ 69,387 Cash 2022: € 69,387 First fiscal year in the series	€ 134,411 Cash 2023: € 134,411 ▲ 94% vs 2022 (€ 69,387) Favourable step	€ 218,062 Cash 2024: € 218,062 ▲ 62% vs 2023 (€ 134,411) Favourable step	€ 232,811 Cash 2025: € 232,811 ▲ 7% vs 2024 (€ 218,062) Favourable step	▲ 7%
Retained profit	€ 63,867 Retained profit 2022: € 63,867 First fiscal year in the series	€ 63,867 Retained profit 2023: € 63,867 Unchanged (€ 63,867) Unchanged	€ 63,867 Retained profit 2024: € 63,867 Unchanged (€ 63,867) Unchanged	€ 63,867 Retained profit 2025: € 63,867 Unchanged (€ 63,867) Unchanged
Bank debt	€ 156,311 Bank debt 2022: € 156,311 First fiscal year in the series	€ 118,227 Bank debt 2023: € 118,227 ▼ 24% vs 2022 (€ 156,311) Favourable step	€ 79,550 Bank debt 2024: € 79,550 ▼ 33% vs 2023 (€ 118,227) Favourable step	€ 40,256 Bank debt 2025: € 40,256 ▼ 49% vs 2024 (€ 79,550) Favourable step	▼ 49%
Balance sheet total	€ 755,737 Balance sheet total 2022: € 755,737 First fiscal year in the series	€ 1,004,540 Balance sheet total 2023: € 1,004,540 ▲ 33% vs 2022 (€ 755,737) Unchanged	€ 1,196,590 Balance sheet total 2024: € 1,196,590 ▲ 19% vs 2023 (€ 1,004,540) Unchanged	€ 1,107,030 Balance sheet total 2025: € 1,107,030 ▼ 7% vs 2024 (€ 1,196,590) Unchanged	▼ 7%
Employees (FTE)	3.9 Employees (FTE) 2022: 3.9 First fiscal year in the series	4.3 Employees (FTE) 2023: 4.3 ▲ 0.4 vs 2022 (3.9) Unchanged	4.4 Employees (FTE) 2024: 4.4 ▲ 0.1 vs 2023 (4.3) Unchanged	4.6 Employees (FTE) 2025: 4.6 ▲ 0.2 vs 2024 (4.4) Unchanged	▲ 0.2

Key figures of NOORD LIMBURGSE DIENST UROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NOORD LIMBURGSE DIENST UROLOGIE?

What happened at NOORD LIMBURGSE DIENST UROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
2024 Dr. K. De Coster BV became a director. NBB
2024 Naturo BV became a director. NBB
2024 Dr. Van Dyck Johan BV became a director. NBB
2024 Dr. Stijn Schapmans BV became a director. NBB
2024 Dokter Tom Vandewalle BV became a director. NBB
Nov 27, 2018 New establishment in Pelt. KBO
Nov 27, 2018 Start of the company according to the CBE. KBO

In short

From € 12,690 profit in 2022 to € 0 profit in 2025.

Paid € 1,636 in corporate taxes since 2022.

Best year ever: 2022, with € 12,690 profit.

On average € 105,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at NOORD LIMBURGSE DIENST UROLOGIE? We notify you, reason included.

Follow NOORD LIMBURGSE DIENST UROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

DOKTER PHILIP FRANSEN 25%

Dr. Stijn Schapmans 25%

DOKTER S. VERMEERSCH 16.7%

The stake of DOKTER PHILIP FRANSEN, Dr. Stijn Schapmans, DOKTER S. VERMEERSCH comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

NOORD LIMBURGSE DIENST UROLOGIE

Behind NOORD LIMBURGSE DIENST UROLOGIE are Dr. K. De Coster BV, Naturo BV, Dr. Van Dyck Johan BV, Dr. Stijn Schapmans BV and Dokter Tom Vandewalle BV. The shares are held by DOKTER PHILIP FRANSEN (25%), Dr. Stijn Schapmans (25%) and DOKTER S. VERMEERSCH (16.7%).

See the full network in the app